A2B-COVID: A Tool for Rapidly Evaluating Potential SARS-CoV-2 Transmission Events.
Saved in:
| Title: | A2B-COVID: A Tool for Rapidly Evaluating Potential SARS-CoV-2 Transmission Events. |
|---|---|
| Authors: | Illingworth CJR; MRC-University of Glasgow Centre for Virus Research, Glasgow, United Kingdom.; MRC Biostatistics Unit, University of Cambridge, Cambridge, United Kingdom.; Department of Applied Mathematics and Theoretical Physics, University of Cambridge, Cambridge, United Kingdom.; Institut für Biologische Physik, Universität zu Köln, Köln, Germany., Hamilton WL; Department of Medicine, University of Cambridge, Cambridge, United Kingdom.; Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom., Jackson C; MRC Biostatistics Unit, University of Cambridge, Cambridge, United Kingdom., Warne B; Department of Medicine, University of Cambridge, Cambridge, United Kingdom.; Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom., Popay A; Public Health England Field Epidemiology Unit, Cambridge Institute of Public Health, Cambridge, United Kingdom., Meredith L; Department of Pathology, Division of Virology, University of Cambridge, Cambridge, United Kingdom., Hosmillo M; Department of Pathology, Division of Virology, University of Cambridge, Cambridge, United Kingdom., Jahun A; Department of Pathology, Division of Virology, University of Cambridge, Cambridge, United Kingdom., Fieldman T; Department of Medicine, University of Cambridge, Cambridge, United Kingdom.; Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom., Routledge M; Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom.; Clinical Microbiology and Public Health Laboratory, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom., Houldcroft CJ; Department of Medicine, University of Cambridge, Cambridge, United Kingdom., Caller L; Francis Crick Institute, London, United Kingdom., Caddy S; Cambridge Institute for Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, Cambridge, United Kingdom., Yakovleva A; Department of Pathology, Division of Virology, University of Cambridge, Cambridge, United Kingdom., Hall G; Department of Pathology, Division of Virology, University of Cambridge, Cambridge, United Kingdom., Khokhar FA; Department of Pathology, Division of Virology, University of Cambridge, Cambridge, United Kingdom., Feltwell T; Department of Medicine, University of Cambridge, Cambridge, United Kingdom., Pinckert ML; Department of Pathology, Division of Virology, University of Cambridge, Cambridge, United Kingdom., Georgana I; Department of Pathology, Division of Virology, University of Cambridge, Cambridge, United Kingdom., Chaudhry Y; Department of Pathology, Division of Virology, University of Cambridge, Cambridge, United Kingdom., Curran M; Clinical Microbiology and Public Health Laboratory, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom., Parmar S; Clinical Microbiology and Public Health Laboratory, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom., Sparkes D; Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom.; Clinical Microbiology and Public Health Laboratory, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom., Rivett L; Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom.; Clinical Microbiology and Public Health Laboratory, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom., Jones NK; Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom.; Clinical Microbiology and Public Health Laboratory, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom., Sridhar S; Department of Medicine, University of Cambridge, Cambridge, United Kingdom.; Cambridge Institute for Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, Cambridge, United Kingdom.; Wellcome Sanger Institute, Hinxton, United Kingdom., Forrest S; Francis Crick Institute, London, United Kingdom., Dymond T; Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom., Grainger K; Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom., Workman C; Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom., Gkrania-Klotsas E; Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom.; MRC Epidemiology Unit, University of Cambridge, Level 3 Institute of Metabolic Science, Cambridge, United Kingdom.; School of Clinical Medicine, University of Cambridge, Cambridge, United Kingdom., Brown NM; Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom.; Clinical Microbiology and Public Health Laboratory, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom., Weekes MP; Department of Medicine, University of Cambridge, Cambridge, United Kingdom.; Cambridge Institute for Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, Cambridge, United Kingdom., Baker S; Department of Medicine, University of Cambridge, Cambridge, United Kingdom.; Cambridge Institute for Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, Cambridge, United Kingdom., Peacock SJ; Department of Medicine, University of Cambridge, Cambridge, United Kingdom.; Wellcome Sanger Institute, Hinxton, United Kingdom., Gouliouris T; Department of Medicine, University of Cambridge, Cambridge, United Kingdom.; Clinical Microbiology and Public Health Laboratory, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom., Goodfellow I; Department of Pathology, Division of Virology, University of Cambridge, Cambridge, United Kingdom., Angelis D; MRC Biostatistics Unit, University of Cambridge, Cambridge, United Kingdom.; Public Health England, National Infection Service, London, United Kingdom., Török ME; Department of Medicine, University of Cambridge, Cambridge, United Kingdom.; Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom. |
| Source: | Molecular biology and evolution [Mol Biol Evol] 2022 Mar 02; Vol. 39 (3). |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Oxford University Press Country of Publication: United States NLM ID: 8501455 Publication Model: Print Cited Medium: Internet ISSN: 1537-1719 (Electronic) Linking ISSN: 07374038 NLM ISO Abbreviation: Mol Biol Evol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1537-1719 |
|---|---|
| DOI: | 10.1093/molbev/msac025 |
